Galton D J, Mattu R, Needham E W, Cavanna J
Medical Professorial Unit, St Bartholomew's Hospital, London, U.K.
Z Gastroenterol. 1996 Jun;34 Suppl 3:56-8.
To determine the effect of a common mutation (Ser447-Ter) of the human LPL gene upon serum lipid and lipoprotein levels and coronary artery disease (CAD) within a representative adult male population, we analyzed subjects from the Caerphilly Prospective Heart Disease Study (n = 1273). The possession of this mutation associates with protective lipid and lipoprotein profiles. Subjects possessing the mutation have significantly higher HDL-C (p = 0.002) and apo AI (p < 0.04) levels, lower triglycerides (p = < 0.04) and total cholesterol/HDL-C ratios (p < 0.02); all established previously to reduce risk of CAD. We also find that this mutation is significantly less frequent amongst CAD subjects (p < 0.05). These associations provide evidence for a common mutation that appears to confer beneficial lipid and lipoprotein profiles amongst an adult male population with regard to risk of CAD.
为了确定人类脂蛋白脂肪酶(LPL)基因的常见突变(Ser447-Ter)对具有代表性的成年男性人群的血脂、脂蛋白水平及冠状动脉疾病(CAD)的影响,我们分析了来自卡菲利前瞻性心脏病研究的受试者(n = 1273)。拥有这种突变与保护性血脂和脂蛋白谱相关。携带该突变的受试者具有显著更高的高密度脂蛋白胆固醇(HDL-C)水平(p = 0.002)和载脂蛋白AI(apo AI)水平(p < 0.04),更低的甘油三酯水平(p = < 0.04)以及总胆固醇/HDL-C比值(p < 0.02);所有这些指标先前均已证实可降低CAD风险。我们还发现,这种突变在CAD受试者中出现的频率显著更低(p < 0.05)。这些关联为一种常见突变提供了证据,该突变似乎在成年男性人群中就CAD风险而言赋予了有益的血脂和脂蛋白谱。